Tag Archives: from


Linear Actuator for Harsh or Wet Conditions From Specialty Motions, Inc.

Corona, CA (PRWEB) April 15, 2015

The ECO60 from Specialty Motions, Inc. is a low cost US made Linear Actuator built for tough industrial applications where harsh, wet and dirty environments are considered standard. iglide™ bearing materials from Igus™ are encapsulated in an adjustable carriage for precise and custom fit and feel sliding on precision ground aluminum shafting Hardcoat plated for optimal wear, excellent coefficient of friction and predicable life. More Info


The ECO60 Linear Actuator was built to satisfy eight major objectives;

1.    Be a low cost US option to the Asian linear actuator models.

2.    Offer excellent load capacity, smooth operation, and predictable life.

3.    Be a solution for harsh, wet applications as a standard product

4.    Offer an adjustable carriage to provide for a customize fit and wear compensation

5.    Offer a repair kits for quick, easy rebuild when necessary

6.    Offer lead screw pitch options for customizing to application speed and travel needs

7.    Be Readily available for immediate delivery

Product Description

Size for size, the ECO60 fits the Asian Linear Actuator model being 60mm wide and 33mm tall. That’s where the similarities end. The ECO60 with a pre-loadable carriage top can be adjusted to suit your needs. Find the perfect balance between snug fit and smooth linear motion. As the sliding elements wear, make adjustments to correct until they are worn out and then replace them with our SMI ECO60 repair kits.

Harsh Environment Ready

This Hardcoat shafting combined with the iglide linear sliding elements from Igus makes the ECO60 ideal for harsh or wet conditions including diluted lyes, weak acids, cleaning agents used in wash down applications, Alcohol, hydrocarbons, grease and oils with additives, fuels and strong alkalizes.

For added corrosion protection and durability, the ECO60 Lead screw is stainless steel, drive nut is a pre-loaded resin for reduced backlash, end support bearings are all stainless steel, motor coupler is wire cut, stainless steel making the ECO60 ideal for wet, harsh environments.

Durable Design

The ECO60 is made to be tough and durable. The Base, end plates and top carriage are all made from 6061T6 aluminum and machined to have all surfaces and planes be within .002”. These aluminum surfaces are then anodized for strength and durability.

The SMI Hardcoat shafting is then machined to a custom configuration and length and is matched to the machined base. The rails are then snapped into perfect place insuring precision alignment to all surfaces.

The ECO60 Carriage

The ECO60 carriage is made from aluminum billet with all surfaces machined to allow for correct contact and conformity between iglide elements and Hardcoat shafting to allow for smooth, efficient linear motion. Carriages are then anodized to SMI standards and Helicoils threaded inserts are inserted into the carriage pre-load adjusting screw for durability and strength.

The iglide linear elements sit in specially machined notches to maintain alignment and make assembly simple.

With sliding elements such as in the ECO60, being used in a variety of applications, some bearings will wear more rapidly than others. However, that is not a problem. As the ECO60 wears, simply re-adjust the carriage pre-load to get whatever feel or snugness you are trying to achieve. If the sliding element becomes too worn that too is fixable.

The ECO60 Repair Kit

SMI Offers a repair kit which includes all stainless steel end support bearings, lead screw nut, iglide sliding elements, stainless steel motor coupler, complete instructions and a lubrication pen. Within minutes you will be back up and running and fully functional.

To view more Linear Actuator solutions form Specialty Motions, Inc., visit our Actuator link

Company Information:

Specialty Motions, Inc., (SMI), located in Southern California, has been creating and developing motion control and automation devices, components and systems under the SMI and smi4motion.com brand since 1990. With 25 years of business under the same management in this tough competitive industry speaks volumes regarding quality, craftsmanship and the ability to deliver solutions.

Contact SMI at Engineering@smi4motion.com with any technical questions, sales(at)smi4motion(dot)com with any questions regarding pricing for the New ECO60 or any of the many other forms of Linear Actuators.

Contact Specialty Motions, Inc. at 800-283-3411 for answers to your linear actuator applications.


Topamax Birth Injury Resources and the Wall Street Journal Report on Growing Concern over Potential Birth Defects from Topamax

(PRWEB) March 30, 2011

On March 29, 2011 the Wall Street Journal covered the growing concern surrounding birth defects related to drugs taken by women during pregnancy (Can Mom’s Medicine Hurt the Baby, March 29, 2011, Wall Street Journal). The article was spurred by the fact that in early March, the FDA released a MedAlert Safety Update regarding the pregnancy category classification of the popular migraine drug Topamax (also known as Topiragen or topiramate). (Topamax (topiramate): Label Change – Risk For Development of Cleft Lip and/or Cleft Palate in Newborns, March 4, 2011, FDA.gov).

In February of 2011, the FDA also announced that certain antipsychotic drugs including Haldol, Zyprexa, Seroquel and Abilify, among others, could cause withdrawal symptoms such as agitation and difficulty breathing and feeding in newborns if the baby is exposed to any of these drugs en utero. (Antipsychotic Drugs Used During Pregnancy Could Harm Newborn, FDA.gov).

As the WSJ notes, some of the first conclusive evidence that a drug could cross the placenta and cause potential harm to a fetus occurred in the 1960’s when over 10,000 babies were born with missing or shrunken limbs after their mothers took thalidomide, a morning-sickness drug and sleep aid. (Can Mom’s Medicine Hurt the Baby, March 29, 2011, Wall Street Journal)

The recent Topamax announcement surrounds reports by the North American Antiepileptic Drug (NAAED) Pregnancy Registry suggesting that oral deformities such as cleft lip and cleft palate may be linked to the use of Topamax during pregnancy. Specifically, the NAAED cites that the existence of major malformations was 3.8% in the topiramate-exposed group of infants versus 1.3% in the unexposed reference group. The prevalence of cleft lip was 0.69% versus the expected rate of .07% in the normal population. (Herndandez-Diaz, S., Mittendorf, R., Holmes L.B. Comparative Safety of Topiramate During Pregnancy. Birth Defects Research (Part A); 88:408 (2010).)

The NAAED Pregnancy Registry was established in 1997 by Massachusetts General Hospital to study the safety of anticonvulsant drugs taken during pregnancy.

The FDA has encouraged the creation of such pregnancy registries as a responsible way to study and report on birth defects from anticonvulsants and other medication. Some of the difficulties in understanding birth defects from drugs such as Topamax lie in the fact that it is not considered ethical to include pregnant women or unborn children in clinical drug trials.

As a result, the labels on a large number of medications have next to no information about the potential harm they may cause to a mother or a fetus. A label may advise a women to seek the consult of her doctor, however, many of these physicians are often baffled since conclusive data on safety in pregnancy does not exist for so many prescription drugs.(Can Mom’s Medicine Hurt the Baby, March 29, 2011, Wall Street Journal)

However, despite the fact that drugs are not tested on pregnant women, millions of these women take medications each year. The WSJ article reports that as many as 60% of women take at least one prescription drug during their pregnancy, and on average, women use three to five. (Can Mom’s Medicine Hurt the Baby, March 29, 2011, Wall Street Journal)

The birth defects allegedly linked to Topamax – cleft palate and cleft lip, are known as oral-facial clefts. The severity of potential cleft palate from Topamax ranges from a small gap in the lip to a gaping hole in the roof of the mouth. Cleft palate can affect the hard or soft palates of the mouth and often require numerous surgeries to repair the condition. Children with cleft palate often require special feeding bottles or tubes to get proper nutrition and may be outfitted with an artificial palate prior to surgery. These children are especially prone to chronic ear infections as excess fluid from the mouth drains into the ear canal.

Oral-facial clefts such as cleft palate occur very early in the stages of fetal development. The tissues which will become the lip fuse around 5 – 6 weeks of development, where the palate forms around 7 weeks.

Many of the concerns about the birth defects of Topamax and other anticonvulsant drugs is the fact that the alleged birth defects occur during this early stage of fetal development. During this time many women are not even aware that they are pregnant yet and they may unwittingly be taking the drug without knowing the potential damage it could be causing.

Women or families seeking more information about the alleged birth risks of Topamax are encouraged to visit the online resource of TopamaxBirthInjury.com. Topamax Birth Injury Resources offers a free, no-obligation claim review form which families can submit to a qualified Topamax attorney to review their injuries for a potential Topamax lawsuit.



Mental Health Watchdog Applauds New Mexico Lawmakers for Protecting Children from Forced Psychotropic Drugging

Los Angeles, California (PRWEB) April 14, 2015

In a new article, Citizens Commission on Human Rights (CCHR), the mental health watchdog, applauds New Mexico lawmakers for taking a big step toward protecting children’s and parents’ rights when, last week, Governor Susana Martinez signed into law House Bill 53 ensuring that a parent’s decision not to administer psychotropic drugs to a child is not grounds for a child being removed from parental custody by Child Protective Services (CPS).[1]

And the legislation goes deeper. The bill, sponsored by State Rep. Nora Espinoza, also restricts school personnel from taking any action against the parent or compelling or requiring any student to take a psychotropic drug and, further, requires written parental consent prior to any psychological screening.[1]

CCHR stated, “It’s encouraging that New Mexico is taking its place among a growing list of states taking protective actions on behalf of children and parental rights.”

In light of the 8.4 million children currently being prescribed psychiatric drugs in the United States, CCHR asserts that states must strive to protect parents from being forced by CPS or pressured by school personnel to administer these drugs to their child.[2] To date, thirteen states, including the recently enacted legislation in New Mexico, have passed legislation addressing parental rights as they pertain to refusing psychiatric drugs, restricting removal of children by CPS based solely on the parent’s refusal to administer psychiatric drugs to a child and coercion of parents to submit their child to mental health screening. These states include:

    Florida and Colorado both have passed laws providing enhanced rights to parents, including the right to refuse psychiatric testing/screening and/or provide written consent prior to any screening and, further, to prohibit school personnel from recommending the use of psychiatric drugs and/or make it so the refusal of a parent to consent to the administration of a psychiatric drug to their child is not a condition of the child attending school.[3]

    Most notably, Florida currently has a bill (HB 209) that directly addresses psychiatry’s diagnosing manual, stating that before a student is evaluated for the purpose of diagnosing the child with any disorder listed in the Diagnostic and Statistical Manual of Mental Disorders (DSM), the parent shall be notified of all of the following:

    The behaviors prompting the evaluation could be the result of underlying physical conditions.

    The parent should consider consulting a medical doctor to rule out physical causes.

    The parent has the right to decline the evaluation.

    The evaluation and subsequent classification or placement may be documented on the student’s cumulative record.[4]

    Five states, including Illinois, Minnesota, Oregon, Texas and Virginia, have passed legislation prohibiting school personnel from recommending the use of psychiatric drugs and/or prohibiting the refusal of a parent to consent to the administration of a psychiatric drug to a child from being a condition of the student attending school.[5]

    Additionally, Utah, New Hampshire, Arizona and now New Mexico, have enacted legislation protecting parents from having their children removed by CPS based on the grounds of medical neglect for refusing to administer a psychiatric drug to their child.[6]

    In Michigan, in response to the well-publicized case of the harrowing armed assault against Maryanne Godboldo for refusing to drug her daughter, the Department of Children and Families changed its policy, reflecting the public outcry and stating “CPS is not responsible for investigating complaints that allege parents are failing or refusing to provide their children with psychotropic medication such as Ritalin.”[7]

CCHR says, “That Florida is the first state to specifically address psychiatry’s diagnostic manual is of note and a primer for future legislative action—a first step in initiating a much-needed conversation about the increased psychiatric diagnosing and administering of psychiatric drugs to America’s children.”

Read the full article here.

About Citizens Commission on Human Rights: CCHR is a non-profit, non-political, non-religious mental health watchdog. Its mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections. CCHR has helped to enact more than 150 laws protecting individuals from abusive or coercive mental health practices.


[1] House Bill 53, “No Compelled Medication Use for Students,” New Mexico 2015 Regular Session, April 7, 2015, nmlegis.gov/Sessions/15%20Regular/final/HB0053.pdf.

[2] IMS, Vector One: National (VONA) and Total Patient Tracker (TPT) Database, Years 2008-2013, Extracted 2014, cchrint.org/psychiatric-drugs/children-on-psychiatric-drugs/.

[3] Senate Bill 1766, “An Act Relating to Administration of Medication to Public School Students,” Florida Legislature, 2005 Regular Session, leg.state.fl.us/cgi-bin/view_page.pl?Tab=session&Submenu=1&FT=D&File=sb1766c1.html&Directory=session/2005/Senate/bills/billtext/html/; House Bill 03-1172, “An Act Concerning School Board Policies Covering When Personnel May Address Health Care Treatment for Student Behavior Issues,” Colorado Legislature, Session Laws of Colorado 2003, June 5, 2003, tornado.state.co.us/gov_dir/leg_dir/olls/sl2003a/sl_387.htm.

[4] House Bill 209, “An Act Relating to Administration of Medication to Public School Students,” Florida Legislature, 2005, myfloridahouse.gov/Sections/Documents/loaddoc.aspx?FileName=_h0209er.docx&DocumentType=Bill&BillNumber=0209&Session=2005.

[5] House Bill 3744, “An Act Concerning Schools,” Illinois Legislature, 92nd General Assembly, ilga.gov/legislation/legisnet92/hbgroups/hb/920HB3744LV.html; House Bill 478, “A Bill for an Act Relating to Education,” Minnesota Legislature, 82nd Legislature (2001-2002), revisor.mn.gov/bills/text.php?number=HF0478&session=ls82&version=list&session_number=0&session_year=2001; Senate Bill 456, “An Act Relating to Students,” Oregon Legislative Assembly, 2003 Regular Session, cchrint.org/pdfs/oregon-sb-456.pdf; House Bill 320, “An Act Relating to the Refusal to Administer or Consent to the Administration of Certain Psychiatric or Psychological Treatment to a Child…,” Texas Legislature, capitol.state.tx.us/Search/DocViewer.aspx?ID=78RHB003205B&QueryText=%22320%22&DocType=B; House Bill 1406, “An Act Relating to a Recommendation by a School District Employee Concerning a Use of a Psychotropic Drug by a Student…,” Texas Legislature, capitol.state.tx.us/Search/DocViewer.aspx?ID=78RHB014065B&QueryText=%221406%22&DocType=B; House Bill 90, “An Act to Amend the Code of Virginia by Adding a Section Numbered 22.1-274.3, Relating to Certain Medication Recommendations by School Personnel,” Virginia Legislature, 2002 Session, lis.virginia.gov/cgi-bin/legp604.exe?021+ful+CHAP0314.

[6] House Bill 170, “Prescribing Psychiatric Drugs or Medication,” Utah Legislature, 2001 General Session, le.utah.gov/~2001/bills/hbillint/HB0170.pdf; House Bill 551, “An Act Relative to the Effect of Parental Refusal to Administer Psychotropic Drugs to their Children…,” New Hampshire Legislature, 2004 Session, gencourt.state.nh.us/legislation/2004/HB0551.html; House Bill 2024, “An Act Amending Sections 8-201 and 8-201.01,” Arizona Legislature, Second Special Session 2003, azleg.gov/legtext/46leg/2s/laws/0006.pdf.

[7] State of Michigan Department of Human Services, “Mandated Reporter’s Guide,” DHS Pub 112 (Rev. 2-13), michigan.gov/documents/dhs/Pub-112_179456_7.pdf; Case No. 11057748-01, 36 District Court, Detroit, Michigan, filed 03/27/2011; Heather Catallo, “Mom Who Chose to Take Daughter Off Medication Files Lawsuit…,” ABC 7, WXYZ Detroit, 10 May 2012, wxyz.com/news/local-news/investigations/mom-who-chose-to-take-daughter-off-medication-files-lawsuit-alleges-daughter-deprived-of-prosthesis.


Following Wall Street Journal Report on Birth Injury From Prescription Medications, RX Birth Defects Releases New Resources for Alleged Victims of Topamax

(Vocus/PRWEB) April 12, 2011

On March 29, 2011 the Wall Street Journal covered the growing concern surrounding birth defects related to prescription medications taken by women during pregnancy. The article, entitiled “Can Mom’s Medicine Hurt The Baby?” examines the history of drug approval in the United States, as well as the lack of appropriate measures to determine dangers to pregnant women and unborn children (Can Mom’s Medicine Hurt the Baby, March 29, 2011, Wall Street Journal).

The article was spurred by the fact that in March of 2011, the FDA released a new MedAlert Safety Update regarding the pregnancy category classification of the popular migraine drug Topamax (also known as Topiragen or topiramate). (Topamax (topiramate): Label Change – Risk For Development of Cleft Lip and/or Cleft Palate in Newborns, March 4, 2011, fda.gov). This alert followed a troubling February 2011 annoucement that certain antipsychotic drugs including Haldol, Zyprexa, Seroquel and Abilify, could cause significant withdrawal symptoms after birth if a child is exposed en uteri. (Antipsychotic Drugs Used During Pregnancy Could Harm Newborn, February 2011, fda.gov).

A drug classification change for Topamax means that the drug is now placed in a drug category that indicates “there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans”. (Chart of FDA Pregnancy Categories, fda.gov) The FDA strongly advises that all other options be explored before a woman uses a category D drug during pregnancy and that the drug only be used if the risk to the mother outweighs the potential risk to the fetus.

The specific Topamax re-classification was encouraged by evidence presented by the North American Antiepileptic Drug (NAAED) Pregnancy Registry suggesting that oral-facial deformities such as cleft lip and cleft palate may be linked to the use of Topamax during pregnancy. Specifically, the NAAED cites that the existence of major malformations was 3.8% in the topiramate-exposed group of infants versus 1.3% in the unexposed reference group. The prevalence of cleft lip was 0.69% versus the expected rate of .07% in the normal population. (Source: Herndandez-Diaz, S., Mittendorf, R., Holmes L.B. Comparative Safety of Topiramate During Pregnancy. Birth Defects Research (Part A); 88:408 (2010).)

Topamax is part of a class of drugs known as “anticonvulsants” or “anti-epileptics”, a class of drugs at the center of the birth defect debate. Numerous other anticonvulsant drugs, including the epileptic and seizure medication Depakote, have been linked to potential birth defects. Depakote, specifically, has been linked to serious neural tube malformations that cause the debilitating condition of spina bifida (Source: The Teratogenicity of Anticonvulsant Drugs, Lewis B. Holmes, M.D., N Engl J Med 2001; 344:1132-1138, April 12, 2001).

Currently, no comprehensive testing of potential drug risks for pregnant or breastfeeding women or unborn children exists. The ethical issues surrounding testing on these demographic groups prevents organized studies for this population. As a result, many of the birth defects that may be related to prescription drugs are not discovered until after the drug is released to the public and physicians or drug registry programs begin reporting a pattern of birth injuries.

RXBirthDefects.com is part of the family of resource websites created by the Consumer Justice Foundation, an online consumer watchdog agency. Following the Wall Street Journal article and the FDA classification change for Topamax, RXBirthDefects.com added a resource section dedicated to providing information about potential birth defects related to Topamax use during pregnancy.

The Topamax birth defect information covered on RXBirthDefects.com includes detailed information about the oral-facial malformations and genital malformations that may be related to the drug use. This includes facial clefts such as cleft lip, cleft palate and the male genital deformation of hypospadias (Source: Herndandez-Diaz, S., Mittendorf, R., Holmes L.B. Comparative Safety of Topiramate During Pregnancy. Birth Defects Research (Part A); 88:408 (2010)).

Families seeking legal recourse for birth injuries related to Topamax taken during pregnancy can find more information about how to file a Topamax lawsuit and updated news on the status of ongoing Topamax litigation in the United States. Families can connect immediately with reputable Topamax attorneys and legal representation via the free case evaluation form available online at RXBirthDefects.com.

About RXBirthDefects.com:

RXBirthDefects.com provides comprehensive information and resources regarding the use of prescription medication during pregnancy. The information on RXBirthDefects.com currently covers the prescription anticonvulsants Topamax, Dilantin, Depakote and Tegretol as well as the common antidepressants Celexa, Lexapro, Paxil, Pristiq, Prozac and Zoloft. The website provides an online resource center and free claim review form for women and families seeking more information about the specific birth defects that may be related to these drugs when used during pregnancy.

# # #


Avoiding Addiction When Powerful Opioid Painkillers Are Needed, From the November 2013 Harvard Health Letter

Boston, MA (PRWEB) November 12, 2013

Sometimes the best way to ease pain is with the type of prescription painkiller known as an opioid. Despite their “addictive” reputation in the media, the majority of people use opioids safely and without addition, reports the November 2013 Harvard Health Letter.

Opioids are a class of painkillers with high addictive potential. They include oxycodone (OxyContin), hydrocodone (Vicodin), hydromorphone (Dilaudid), and meperidine (Demerol). Opioids are typically used for the short term, such as for treating severe pain following surgery. They are also sometimes used long-term for relieving pain related to cancer or a terminal illness.

For minor surgical pain or injuries, it’s best to limit the use of an opioid to no more than seven days. Using one for more than 30 days leads to dependence. That means a person begins to suffer withdrawal symptoms if he or she abruptly stops taking the medication. With long-term use, some individuals need more of these drugs to achieve the same effect. Keep in mind that dependence is not the same as addiction, which is characterized by compulsive use and preoccupation with the drug that interferes with normal life.

For long-term use, take opioids by the clock as prescribed, advises Dr. Karsten Kueppenbender, an addiction psychiatrist at Harvard-affiliated McLean Hospital. Trying to reduce addiction risk by cutting back on the medication and waiting until the pain gets really bad isn’t a good strategy, and can actually backfire. The memory of how bad the pain got, and the sense of relief from the opioid, could actually increase the risk of becoming addicted.

The key to avoiding addiction is the assistance of a medical team that’s easily accessible, along with regular checkups to reassess the need for—and use of—the drug.

Read the full-length article: “Caution: These are the most addictive pain meds”.

Also in the November 2013 issue of the Harvard Health Letter:

    Steps for coping with mild cognitive impairment
    The best fruits and veggies for fall
    An anti-falling checklist to take stock of trip hazards in the home

The Harvard Health Letter is available from Harvard Health Publications, the publishing division of Harvard Medical School, for $ 16 per year. Subscribe at http://www.health.harvard.edu/health or by calling 877-649-9457 (toll-free).


Teen Writing Contest About Mental Health Issues Gets Support From Published Authors Donating Autographed Books Reports StageofLife.com

Minneapolis, MN (PRWEB) March 27, 2014

Online writing community, StageofLife.com, announced today that eleven, internationally published authors will be donating an autographed copy of their book as part of the winning prize packages for the teen finalists of the website’s “March Madness” writing contest dealing with mental health issues.

As an educational resource, StageofLife.com’s mission is to change the world through storytelling, and its award-winning, blogging platform welcomes close to a million teens, college students, teachers, and parents each year who come to the site to read and share their personal, real-life stories.

The site often collaborates with authors based on the topics of its writing prompts.

“We are overwhelmed at the support by the professional writing community as they donate autographed copies of their books for this month’s writing contest on mental illness and health,” said Rebecca Thiegs, VP of Education StageofLife.com.

Participating authors who are donating a signed copy of their book on mental health as a prize to the winning “March Madness” contest finalists include:

–Susannah Cahalan – “Brain on Fire: My Month of Madness” (Simon & Schuster)

–Marya Hornbacher – “Madness: A Bipolar Life” (Mariner Books)

–Randye Kaye – “Ben Behind His Voices: One Family’s Journey from the Chaos of Schizophrenia to Hope” (Rowman and Littlefield Publishers)

–Melody Moezzi – “Haldol and Hyacinths: A Bipolar Life” (Avery Trade)

–Stacy Pershall – “Loud in the House of Myself” (W.W. Norton & Company)

–Elyn Saks – “The Center Cannot Hold: My Journey Through Madness” (Hyperion)

–Lizabeth D. Schuch – “More Than Bipolar: A Memoir of Acceptance and Hope” (iUniverse)

–Karen Winters Schwartz – “Where Are the Cocoa Puffs? A Family’s Journey through Bipolar Disorder” and “Reis’s Pieces – Love, Loss, and Schizophrenia” (Goodman Beck Publishing)

–Andrew Solomon – “The Noonday Demon: An Atlas of Depression” (Scribner)

–Pamela Spiro Wagner – “Divided Minds: Twin Sisters and Their Journey Through Schizophrenia” (St. Martin’s Griffin)

–Fletcher Wortmann – “Triggered: A Memoir of Obsessive Compulsive Disorder” (Thomas Dunne Books)

When asked about her participation with Stage of Life writing contest, author Stacy Pershall said, “Every time you come out to one person as having a mental health disorder, you change the world. Eliminating stigma happens one person at a time. Just giving someone the vocabulary to address what’s happening to them — for example anorexia, bulimia, self-harm — is a powerful thing…Before I got the right treatment, I was certain I’d die by suicide; it was just a matter of time. Now it’s not all about me. I have to stay alive so I can keep other people alive. Killing myself has ceased to be an option.”

Thiegs added that “People don’t talk about mental health issues or mental illness because of the shame and brokenness surrounding the topic, so this month, while much of the world watches the March Madness college basketball tournament, we want to encourage people to think, write and share a story surrounding the topic of mental health and mental illness.”

Alongside its “March Madness” writing contest, StageofLife.com features educational videos, recommended TED talks, resource reading on mental illness, and a Twitter contest awareness component.

Melody Moezzi, author of “Haldol and Hyacinths: A Bipolar Life,” told StageofLife.com that, “Sharing our stories as people living with mental illness is by far the most powerful way to fight stigma and discrimination. It’s our best weapon against the insidious culture of shame and silence that surrounds mental illness today.”

The StageofLife.com essay contest is open to anyone aged 13 years and older. Stories must be original, non-fiction, and 500 words or less. There is no entry fee and submissions are due March 31, 2014 by midnight Pacific Time US.

In addition to receiving a signed book, the 1st Place student writer will also receive gift cards from literacy sponsors IHOP and Papa John’s while the 1st Place adult writer will receive gift cards from Applebee’s and SpaWeek.

Finalists and Winners will be posted on the essay winner’s page and Teen Trend Report after April 20th, 2014.

To get details and submit a story to the March Madness writing contest, visit http://www.StageofLife.com.

Mature Services Gets a Helping Hand from Subaru

AKRON, OH (PRWEB) April 13, 2015

Mature Services is proud to announce receiving a $ 1,000 grant from Meals on Wheels America, through participating in Subaru of America’s “Share the Love” event in 2014/2015.

“The funds will be used to purchase a Cambro food carrier for Mature Services’ Nutrition program that will enable food to maintain proper, hot holding temperatures and ensure our clients receive safe, quality meals,” said Linda Valentine, President & CEO of Mature Services, Inc.

In addition, the Cambro food carrier will eliminate drivers from returning to Mature Services’ nutrition locations twice per day for more meal deliveries. Over 10 years, this grant will help Mature Services fight senior hunger and isolation by enabling us to provide an additional 10,381 meals that will impact 1,730 seniors in need.

“We were honored to participate in the “Share the Love” event this year,” said Valentine. “It is the generous support of organizations like Meals on Wheels America and Subaru America that make it possible for Mature Services to continue to serve older adults in the community,” Valentine added.

Mature Services provides programs including homecare, alcohol, substance abuse and gambling treatment and prevention, mental health counseling, job training, home delivered and congregate meals, volunteer opportunities and emergency food pantry.

This event was designed as a way for Subaru retailers to give back to communities throughout the United States. Over the past six years, Subaru has donated $ 50 million to charity, focusing this year on fighting against isolation and hunger in the older population.


86% of Teenagers Know Someone Who Suffers from a Mental Illness, Reports Stageoflife.com

York, PA (PRWEB) April 30, 2014

To understand the relationship between teens and mental illness, StageofLife.com asked thousands of high school and college students to take its national poll about mental health issues as part of its monthly writing contests and life surveys.

The results revealed the following statistics about teenagers and mental illness:

–1 out of 2 teens state they have personally struggled with mental illness at some point in their lives.

–Depression and Anxiety ranked #1 and #2 respectively as the most common mental illness suffered by students.

–86% of teenagers say they know someone who suffers from a mental illness.

–46% of students say they have “contemplated” suicide.

–86.5% of students say that mental health issues are an “important” or “very important” topic for the country.

–84.5% of teens think that there is a negative stigma surrounding those with mental illness.

–Half of all teens say classmates and friends are mostly compassionate about those with mental illness.

–73% of high school and college students know someone who is taking medication because of a mental health issue.

Over 5,100 students visited the essay and survey page during the mental health writing prompt and over 400 teens fully answered the poll. An additional 180+ teen bloggers submitted an essay to StageofLife.com sharing their personal story will mental illness.

The winning 1st place student essay, “Fibs and Femurs for Dinner” was written by Emily Bromberg, a junior attending Long Beach High School on Long Island, NY who shared her story of struggling to stay healthy. The winning 1st place non-student essay was submitted by special education teacher, Lauren Bauer from Raleigh, NC in her story, “Alone.”

Stage of Life selected a winner from its “Short Short Story” Twitter contest, which also tied into the mental illness writing prompt. The winning Tweet came from ‏‏@sopxhia who wrote, “Depression is being trapped in my labyrinth of thoughts and having no light to guide my way through the twists of the maze.”

Winners from the writing and Twitter contests received gift cards from StageofLife.com educational corporate sponsors Applebee’s, IHOP, Papa John’s, and SpaWeek.com.

Additionally, the top 12 essay finalists received an autographed copy of a book signed by a nationally published author.

The participating authors who donated a signed book as a prize for the Stage of Life writing contest included…

–Susannah Cahalan – “Brain on Fire: My Month of Madness”

–Marya Hornbacher – “Madness: A Bipolar Life”

–Randye Kaye – “Ben Behind His Voices: One Family’s Journey from the Chaos of Schizophrenia to Hope”

–Melody Moezzi – “Haldol and Hyacinths: A Bipolar Life”

–Stacy Pershall – “Loud in the House of Myself”

–Elyn Saks – “The Center Cannot Hold: My Journey Through Madness”

–Lizabeth D. Schuch – “More Than Bipolar: A Memoir of Acceptance and Hope”

–Karen Winters Schwartz – “Where Are the Cocoa Puffs? A Family’s Journey through Bipolar Disorder and Reis’s Pieces – Love, Loss, and Schizophrenia”

–Andrew Solomon – “The Noonday Demon: An Atlas of Depression”

–Pamela Spiro Wagner – “Divided Minds: Twin Sisters and Their Journey Through Schizophrenia”

–Fletcher Wortmann – “Triggered: A Memoir of Obsessive Compulsive Disorder”

StageofLife.com VP of Education, Rebecca Thiegs, said, “We gave students a safe venue to share their stories about mental illness. It is often a taboo topic, and we’re proud of the bravery of the hundreds of participating teens who submitted an essay this month.”

To read all of the essays about mental illness and download the full teen statistics report on this and other monthly writing contests and teen trends, visit StageofLife.com.

# # #

StageofLife.com is a privately funded, start-up company founded in 2009 by Joe and Eric Thiegs. The website’s mission is to change the world, one story at a time. The site welcomed its 1,000,000th visitor last year and provides an international writing community, resources, videos, statistics, and more for today’s teen, Gen X, Gen Y, and Baby Boomer generations.


Rapid Opiate Detox in Only 8 Hours from Las Vegas Rapid Detox

Las Vegas, NV (PRWEB) June 20, 2014

Opiate detox can be an extremely painful thing to go thorugh. However, with Las Vegas Rapid Detox’s groundbreaking 8 hour rapid detox procedure, patients can detox from opiates in only eight hours without suffering any signs of withdrawal. Las Vegas Rapid Detox’s procedure has been proven safe and in Las Vegas Rapid Detox is please to announce that they have reached the milestone of successfully performing 500 rapid opiate detox procedures without any complications.

Since July 2007, Dr. Thomas Yee, MD, an anesthesiologist with 20 years of clinical experience, certified by the American Board of Anesthesiology, has treated 500 patients from all over the U.S., Canada, the United Kingdom, and Mexico. Performed in certified operating rooms at accredited hospital or surgery centers, the advanced rapid opiate detox procedure (AROD), developed by Dr. Yee, has been used on patients addicted to various opiates including heroin, oxycontin, oxycodone, hydrocodone, fentanyl, dilaudid, vicodin, tramadol, etc.

“The best way to describe what we do is imagining 2 weeks worth of cold-turkey quitting being compressed into 8 hours while the patient sleeps under anesthesia,” Dr. Yee stated. “We know the physical withdrawal in quitting opiates is horrible, but the discomfort is finite; it does not last forever. The trick is to hurry up the withdrawal so the patient can get over it while sleeping.”

After the 8-hour treatment, the patients would receive 48 hours of one-on-one nursing care for recovery. After returning home, patients are required to have weekly counseling for 6 months to treat the psychological aspect of addiction. In order to prevent relapse, patients are also required to receive FDA-approved monthly injection of a long-acting opiate-blocker, Vivitrol, from nearby providers.

To find out more about how Las Vegas Rapid Detox Medical Clinic reached the 500 patient mark without complication, go to http://www.saferapiddetox.com or http://www.rapiddetoxlasvegas.com.


Detox from Opiates in 8 Hours at Las Vegas Rapid Detox

Las Vegas (PRWEB) June 21, 2014

Opiate addiction is something that millions of Americans struggle with every day. Now thanks to Las Vegas Detox Clinic’s groundbreaking new procedure, patients can kick their opiate addiction and go through rapid opiate detox without any significant withdrawal symptoms in only eight hours.

Battling opiate detox symptoms is the main reason opiate addicts continue using. However, at Las Vegas Rapid Detox patients can rest assured that they will be able to detox from opiates without any of the painful withdrawal symptoms in just eight hours.

The procedure was developed by Dr. Thomas Yee and so far successfully treated more than 500 patients for opiate addiction without any complications. Patients go through the 8-hour detox treatment under anesthesia at an accredited and certified hospital or surgery center operating room. The procedure is performed by an M.D. anesthesiologist that is certified by the American Board of Anesthesiology.

The rapid detox proceduere has been used to treat all forms of opiate addiction including heroin, oxycontin, hydrocodone, oxycodone, methadone, Suboxone, and Subutex.

Dr. Yee’s revolutionary rapid opiate detox procedure basically compresses two weeks of cold-turkey quitting into 8 hours. Patients do not feel the intense accelerated withdrawal, the most difficult part of opiate detox, because they are under general anesthesia. Following the rapid detox procedure, patients feel no physical withdrawal, and are treated with 48 hours of continuous, one-on-one, nursing care before they are discharged and sent home to start a new life free from opiate addiction.

To prevent any relapses, patients are required to take opiate blockers for up to a year and undergo one-on-one physical counceling to treat the underlying psychological aspects of addiction.

More information on Las Vegas Rapid Detox Clinics groundbreaking rapid opiate detox procedure is available online at saferapiddetox.com or http://www.rapiddetoxlasvegas.com. They can be contacted by telephone at (800) 276-7021.